Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pre-Exposure Prophylaxis | 3 | 2018 | 1138 | 1.14 | Why? |
| Anti-HIV Agents | 4 | 2018 | 2209 | 1.14 | Why? |
| Hong Kong | 13 | 2020 | 3361 | 0.91 | Why? |
| HIV Infections | 9 | 2018 | 11620 | 0.88 | Why? |
| Influenza Vaccines | 4 | 2020 | 2941 | 0.83 | Why? |
| Lymphoma, Primary Effusion | 1 | 2017 | 11 | 0.71 | Why? |
| Mycobacterium Infections | 1 | 2018 | 72 | 0.70 | Why? |
| CD4-CD8 Ratio | 1 | 2017 | 235 | 0.65 | Why? |
| Herpesvirus 8, Human | 1 | 2017 | 97 | 0.64 | Why? |
| HIV Seropositivity | 1 | 2019 | 320 | 0.64 | Why? |
| Sarcoma, Kaposi | 1 | 2017 | 97 | 0.62 | Why? |
| Substance Abuse Treatment Centers | 1 | 2017 | 106 | 0.62 | Why? |
| Herpesviridae Infections | 1 | 2017 | 172 | 0.59 | Why? |
| Homosexuality, Male | 3 | 2018 | 1158 | 0.57 | Why? |
| Methadone | 1 | 2017 | 296 | 0.55 | Why? |
| HIV | 2 | 2018 | 1116 | 0.54 | Why? |
| Nurses | 2 | 2020 | 2285 | 0.52 | Why? |
| Substance Abuse, Intravenous | 1 | 2017 | 411 | 0.49 | Why? |
| Sexual and Gender Minorities | 2 | 2019 | 1019 | 0.46 | Why? |
| Orthomyxoviridae | 1 | 2020 | 1168 | 0.45 | Why? |
| Intention | 1 | 2020 | 1380 | 0.45 | Why? |
| Opiate Substitution Treatment | 1 | 2017 | 613 | 0.44 | Why? |
| Vaccination | 4 | 2020 | 19050 | 0.44 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.38 | Why? |
| Program Evaluation | 1 | 2017 | 1929 | 0.38 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.37 | Why? |
| Tuberculosis, Pulmonary | 1 | 2018 | 1171 | 0.34 | Why? |
| Influenza, Human | 3 | 2020 | 10779 | 0.34 | Why? |
| Hepatitis C | 1 | 2019 | 1514 | 0.34 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.33 | Why? |
| Long-Term Care | 1 | 2018 | 2047 | 0.31 | Why? |
| Opioid-Related Disorders | 1 | 2017 | 1185 | 0.29 | Why? |
| Antiretroviral Therapy, Highly Active | 3 | 2018 | 952 | 0.28 | Why? |
| Hyperthyroidism | 1 | 2004 | 63 | 0.27 | Why? |
| Travel | 3 | 2020 | 7220 | 0.25 | Why? |
| Patient Acceptance of Health Care | 2 | 2020 | 5002 | 0.25 | Why? |
| Disease Outbreaks | 6 | 2020 | 27595 | 0.24 | Why? |
| CD4 Lymphocyte Count | 2 | 2017 | 1517 | 0.23 | Why? |
| Molecular Diagnostic Techniques | 1 | 2018 | 4239 | 0.23 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.21 | Why? |
| Seasons | 2 | 2020 | 4071 | 0.17 | Why? |
| Asia, Southeastern | 1 | 2018 | 390 | 0.17 | Why? |
| Condoms | 1 | 2018 | 235 | 0.17 | Why? |
| Tokyo | 1 | 2019 | 645 | 0.16 | Why? |
| Yellow fever virus | 1 | 2018 | 205 | 0.16 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.15 | Why? |
| Quality-Adjusted Life Years | 1 | 2018 | 511 | 0.15 | Why? |
| Adult | 14 | 2020 | 244371 | 0.15 | Why? |
| Yellow Fever | 1 | 2018 | 231 | 0.15 | Why? |
| Religion | 1 | 2018 | 353 | 0.14 | Why? |
| Male | 17 | 2020 | 367725 | 0.13 | Why? |
| Chikungunya virus | 1 | 2017 | 339 | 0.13 | Why? |
| Middle Aged | 14 | 2020 | 270681 | 0.13 | Why? |
| Viral Structural Proteins | 1 | 2017 | 491 | 0.13 | Why? |
| Amino Acid Substitution | 2 | 2017 | 1706 | 0.13 | Why? |
| Molecular Epidemiology | 1 | 2019 | 1638 | 0.13 | Why? |
| Chikungunya Fever | 1 | 2017 | 345 | 0.13 | Why? |
| Humans | 25 | 2021 | 930598 | 0.12 | Why? |
| Vaccination Refusal | 1 | 2020 | 831 | 0.12 | Why? |
| Educational Status | 1 | 2018 | 1451 | 0.11 | Why? |
| Nursing Staff | 1 | 2019 | 542 | 0.11 | Why? |
| Social Behavior | 1 | 2019 | 882 | 0.10 | Why? |
| Socioeconomic Factors | 2 | 2018 | 8495 | 0.10 | Why? |
| Taiwan | 1 | 2019 | 2556 | 0.10 | Why? |
| Bronchoscopy | 1 | 2018 | 991 | 0.10 | Why? |
| Communicable Diseases, Imported | 1 | 2018 | 843 | 0.10 | Why? |
| Anti-Retroviral Agents | 1 | 2018 | 1099 | 0.10 | Why? |
| Social Stigma | 1 | 2018 | 1049 | 0.10 | Why? |
| Mass Screening | 2 | 2021 | 8005 | 0.10 | Why? |
| Hepacivirus | 1 | 2019 | 1509 | 0.10 | Why? |
| Atherosclerosis | 1 | 2017 | 768 | 0.09 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.09 | Why? |
| SARS Virus | 2 | 2020 | 13021 | 0.09 | Why? |
| Analgesics, Opioid | 1 | 2017 | 1070 | 0.09 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.08 | Why? |
| Occupational Stress | 1 | 2020 | 2044 | 0.08 | Why? |
| Female | 11 | 2020 | 380317 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Coinfection | 2 | 2017 | 6820 | 0.08 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.08 | Why? |
| Aged | 5 | 2020 | 215776 | 0.07 | Why? |
| Longitudinal Studies | 2 | 2017 | 9893 | 0.07 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.07 | Why? |
| Dengue | 1 | 2017 | 1565 | 0.07 | Why? |
| Serologic Tests | 1 | 2018 | 4359 | 0.06 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.06 | Why? |
| Cross-Sectional Studies | 3 | 2020 | 53120 | 0.06 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.06 | Why? |
| Republic of Korea | 1 | 2015 | 5858 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.06 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.06 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.06 | Why? |
| Fluorescent Antibody Technique | 1 | 2004 | 835 | 0.05 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.05 | Why? |
| Aging | 1 | 2017 | 3581 | 0.05 | Why? |
| Authoritarianism | 1 | 2020 | 24 | 0.05 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2004 | 12361 | 0.05 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.05 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.05 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.05 | Why? |
| Angola | 1 | 2018 | 75 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.05 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.04 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.04 | Why? |
| Carotid Intima-Media Thickness | 1 | 2017 | 179 | 0.04 | Why? |
| Adiponectin | 1 | 2017 | 123 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Likelihood Functions | 1 | 2017 | 719 | 0.03 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.03 | Why? |
| Aedes | 1 | 2017 | 380 | 0.03 | Why? |
| China | 2 | 2018 | 50654 | 0.03 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.03 | Why? |
| Cross Infection | 1 | 2015 | 8675 | 0.03 | Why? |
| Phylogeography | 1 | 2017 | 824 | 0.03 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.03 | Why? |
| Endemic Diseases | 1 | 2017 | 480 | 0.03 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.03 | Why? |
| Adolescent | 2 | 2017 | 86841 | 0.03 | Why? |
| Neutralization Tests | 1 | 2004 | 6698 | 0.03 | Why? |
| Dengue Virus | 1 | 2017 | 910 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2017 | 2290 | 0.02 | Why? |
| Bayes Theorem | 1 | 2017 | 3237 | 0.02 | Why? |
| Politics | 1 | 2020 | 1824 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Cities | 1 | 2017 | 4937 | 0.02 | Why? |
| Blood Donors | 1 | 2017 | 2956 | 0.02 | Why? |
| Risk Assessment | 2 | 2017 | 25439 | 0.02 | Why? |
| Phylogeny | 1 | 2018 | 13341 | 0.01 | Why? |
| Viral Proteins | 1 | 2017 | 7370 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Viral Vaccines | 1 | 2018 | 7560 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Genome, Viral | 1 | 2017 | 13157 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2004 | 51949 | 0.01 | Why? |
| RNA, Viral | 1 | 2017 | 32276 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
Lee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(148)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(52)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_